Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients

Xiaohang Qiao(The Netherlands Cancer Institute), Jacques Neefjes(Leiden University Medical Center)
Molecular Cancer
June 4, 2024
Cited by 16


Related Papers